| 1 |
Wang Z, Shao SL, Xu XH, Zhao X, Wang MY, Chen A, Cong HY. Helicobacter pylori and gastric microbiota homeostasis: progress and prospects. Future Microbiol 2023. [PMID: 36688318 DOI: 10.2217/fmb-2022-0102] [Reference Citation Analysis]
|
| 2 |
Elbehiry A, Marzouk E, Aldubaib M, Abalkhail A, Anagreyyah S, Anajirih N, Almuzaini AM, Rawway M, Alfadhel A, Draz A, Abu-okail A. Helicobacter pylori Infection: Current Status and Future Prospects on Diagnostic, Therapeutic and Control Challenges. Antibiotics 2023;12:191. [DOI: 10.3390/antibiotics12020191] [Reference Citation Analysis]
|
| 3 |
Bisht N, P. Garg A. Helicobacter pylori Gastric Infection: Pathogenesis and Clinical Management. Helicobacter pylori Infection - An Up to Date on the Pathogenic Mechanisms, Diagnosis and Clinical Management [Working Title] 2022. [DOI: 10.5772/intechopen.106783] [Reference Citation Analysis]
|
| 4 |
Miri AH, Kamankesh M, Llopis-lorente A, Liu C, Wacker MG, Haririan I, Asadzadeh Aghdaei H, Hamblin MR, Yadegar A, Rad-malekshahi M, Zali MR. The Potential Use of Antibiotics Against Helicobacter pylori Infection: Biopharmaceutical Implications. Front Pharmacol 2022;13:917184. [DOI: 10.3389/fphar.2022.917184] [Reference Citation Analysis]
|
| 5 |
Reque PM, Brandelli A. An introduction to probiotics. Probiotics 2022. [DOI: 10.1016/b978-0-323-85170-1.00017-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Mulay V, Satav D, Fernandez A, Pisalwar P, Ahmed S. Development of Probiotics for Helicobacter pylori Infection Management. Alternatives to Antibiotics 2022. [DOI: 10.1007/978-981-19-1854-4_20] [Reference Citation Analysis]
|
| 7 |
Isayev HB, Ibrahimov MR, Salimov TH. Dependence of the state of the large intestine parietal microflora on the activity of Helicobacter pylori associated chronic gastritis. jour 2021;20:44-48. [DOI: 10.52420/2071-5943-2021-20-3-44-48] [Reference Citation Analysis]
|
